Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RESTORE

Financiado

Cerrado

RESTORE Health by Advanced Therapies Advanced Therapy Medicinal Products and Bi...

RESTORE Health by Advanced Therapies Advanced Therapy Medicinal Products and Biologized Medical Devices ALL for Advanced Therapies with Passion For Patients Recently, a new class of living drugs has been developed – Advanced Therapies which aim to transform the current focus of treatment of disease into one that concentrates on restoration of health with promising results in a broad f... ver más

31/07/2020

CHARITE UNIVERSIT...

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-07-31

FETFLAG-01-2018: Preparatory Actions for new FET Fla...

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

CHARITE UNIVERSITAETSMEDIZI...

105.00K€ | Lider

SOTEC ENERGIAS RENOVABLES

390.05K€ | Participante

PLURI BIOTECH LTD

15.00K€ | Participante

INNOVATION ACTA SRL

587.50K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Biorapid Rapid Bioprocess Development 4M€ Cerrado

RenalToolBox Developing novel tools and technologies to assess the safety... 4M€ Cerrado

RESCUE Local Training Network on REgenerative medicine and Stem Cel... 6M€ Cerrado

CTQ2015-73105-EXP DEDALO: HACIA UN NUEVO PARADIGMA EN LA MEDICINA PERSONALIZAD... 54K€ Cerrado

EuroGCT European consortium for communicating gene and cell based t... 3M€ Cerrado

PID2019-105597RA-I00 COSTE EFECTICTIVIDAD DE PRODUCTOS MEDICOS DE TERAPIAS AVANZA... 21K€ Cerrado

Duración del proyecto: 17 meses Fecha Inicio: 2019-02-08
Fecha Fin: 2020-07-31

Líder del proyecto

CHARITE UNIVERSITAETSMEDIZIN BERLIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Recently, a new class of living drugs has been developed – Advanced Therapies which aim to transform the current focus of treatment of disease into one that concentrates on restoration of health with promising results in a broad field of Regenerative Medicine, including targeted immune reconstitution for cancer treatment. Advanced Therapies are game changing in Health Care and have a rapidly expanding market size of approximately 12 and 50 bn € expected by 2020 and 2030, respectively. There is great value in European science and technology on Advanced Therapies but Europe has been losing ground because of scattered and underpowered efforts. If Europe wants a leading role in this emerging field in the future, a mission-driven approach is required to make the transforming promise of Advanced Therapies a reality. The development of new Advanced Therapy products and their implementation in clinical practice will enhance the value-based outcome of patients. Measurable by having dozens of premier-league Advanced Therapy Products discovered & made in Europa by 2030 and beyond. Bringing affordable, standard-of-care for currently incurable diseases which are accessible for every European citizen who need it to RESTORE Health. We propose a mission-driven programme led by the candidate LSRI RESTORE, aiming to build a coordinated, financially strong European partnership between different areas of interest and cross-sectors involving academia, industry, regulatory authorities, health care, patient organisations, and public society. In order to guarantee a smart start of the LSRI from 2021 onwards, the preparation phase aims to involve the growing RESTORE community even more closely in working groups on identified tasks and to jointly complete the RESTORE agenda for Research & Innovation Actions as well as Coordination & Support Actions. The deliverables of RESTORE will allow Europe to gain a world leading health position within this emerging field.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores